The Effects of Ultrasound-guided PRF Versus DN in Myofascial Pain Patients
1 other identifier
interventional
68
0 countries
N/A
Brief Summary
This study aims to compare the effects of pulsed radiofrequency and drying needling and explore the short-term effect of pulsed radiofrequency in treating myofascial pain patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2025
CompletedStudy Start
First participant enrolled
February 25, 2025
CompletedFirst Posted
Study publicly available on registry
February 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 25, 2026
CompletedMarch 7, 2025
March 1, 2025
9 months
February 13, 2025
March 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change of mechanical pain threshold (△MPT)
Mechanical pain threshold was measured by an ergometer called Microfet3. △MPT=MPT4wk (MPT measured at week 4)-MPT 2wk (MPT measured at week 2).
week 0 to week 4
Secondary Outcomes (4)
Severity of pain
week 0 to week 12
Sleep
week 0 to week 12
Depression and anxiety
week 0 to week 12
Life quality
week 0 to week 12
Study Arms (2)
PRF-PRF
EXPERIMENTALDN-PRF
ACTIVE COMPARATORInterventions
Medication: 0-3months; Pulsed radiofrequency: week 2, 6, 10;
Medication: 0-3 months; Dry needling: week 2; Pulsed radiofrequency: week 6, 10;
Eligibility Criteria
You may qualify if:
- Age 18-70 years old, gender unlimited.
- Myofascial pain diagnosed according to the "Simons and Travell" criteria.
- Able to complete treatment and follow-up.
- Signed inform consent form.
You may not qualify if:
- History of surgery, trauma, or infection in the pain area.
- Severe systemic disease, e.g. malignant tumor; severe hepatic, renal, or coagulation disorder; etc.
- Pregnancy, needle phobia, unable to cooperate.
- Concurrently receiving pain treatment in other institutions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 13, 2025
First Posted
February 28, 2025
Study Start
February 25, 2025
Primary Completion
November 25, 2025
Study Completion
March 25, 2026
Last Updated
March 7, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share